Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: Global Cancer Statistics Estimates of Global Incidence and Mortality of 36 Cancers in 185 Countries. Ca Cancer J Clin. 2021; 71:209–49.
Google Scholar
Cao W, Chen HD, Yu YW, Li N, Chen WQ. Changes in cancer burden profiles worldwide and in China: Secondary analysis of global cancer statistics 2020. ChinMed J (ENGL). 2021; 134:783–91.
Google Scholar
Qi D, Wu C, Liu F, Gu K, Shi Z, Lin X, et al. Trends in incidence and mortality of prostate cancer in Shanghai, China from 1973 to 2009. prostate. 2015; 75:1662–8.
Google Scholar
Jamaspishvili T, Kral M, Khomeriki I, Student V, Kolar Z, Bouchal J. Urinary markers in the monitoring of prostate cancer. Prostate cancer prostate diss. 2010; 13:12–9.
Rehman I, Evans CA, Glen A, Cross SS, Eaton CL, Down J, et al. ITRAQ identification of candidate serum biomarkers associated with metastasis progression in human prostate cancer. PLOS 1. 2012; 7: E30885.
Stabile A, Giganti F, Rosenkrantz AB, Taneja SS, Villeirs G, Gill IS, et al. Multiparametric MRI for the diagnosis of prostate cancer: current status and future directions. Nat Rev Urol. 2020; 17:41–61.
Google Scholar
Summers RM. Texture Analysis of Radiology: Does the Emperor have clothes? Abdominal radio (NY). 2017; 42:342–5.
Google Scholar
Avanzo M, Stancanello J, El Naqa I. Beyond Imaging: The Radioactive Promise. Phys Med. 2017; 38:122–39.
Google Scholar
Algohary A, Viswanath S, Shiradkar R, Ghose S, Pahwa S, Moses D, et al. Radioactive function with regard to MRI allows for risk classification of prostate cancer patients with aggressive surveillance: Preliminary findings. j Magneulison Imaging. 2018: https://doi.org/10.1002/jmri.25983.
Liu L, Tian Z, Zhang Z, Fei B. Acad Radio. 2016; 23:1024–46.
Google Scholar
Wang S, Burtt K, Turkbey B, Choyke P, Summers RM. Computer-aided diagnosis of prostate cancer on multiparametric MRI: a technical review of current research. Biomed Rezip. 2014; 2014: 789561.
Google Scholar
Kwon D, Reis IM, Breto AL, Tschudi Y, Gautney N, Zavala-Romero O, et al. Classification of suspicious lesions for prostate multiparametric MRI using machine learning. J Med Imaging (Bellingham). 2018; 5:034502.
Google Scholar
Zhang L, Li LY, Tang M, Huan Y, Zhang XL, Zhe X. A novel approach to diagnose prostate cancer via magnetic resonance imaging. Alex Eng J. 2021; 60:897–904.
Google Scholar
Ellmann S, Schlicht M, Dietzel M, Janka R, Hammon M, Saake M, et al. Computer-aided diagnosis in multiparametric MRI of the prostate: an open-access online tool for high-precision lesion classification. Cancer (Basel). 2020; 12:2366.
Google Scholar
PRISMA 2020 statements including Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD: Updated guidelines for reporting systematic reviews. BMJ. 2021; 372: N71.
Google Scholar
Magnetic resonance imaging-based prediction models for prostate biopsy risk stratification, including Mehralivand S, Shih JH, Rais-Bahrami S, Oto A, Bednarova S, and Nix JW. Jama Oncol. 2018; 4:678–85.
Google Scholar
Quadas-2, including Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB: a revised tool for quality assessment of diagnostic accuracy studies. Unintern Med. 2011; 155:529–36.
Google Scholar
Chen T, Li M, Gu Y, Zhang Y, Yang S, Wei C, et al. Prostate cancer differentiation and aggression: evaluation by a radioactive-based model and PI-RADS V2. j Magneulison Imaging. 2019; 49:875–84.
Google Scholar
Wu M, Krishna S, Thornhill RE, Flood TA, McInnes MDF, Schieda N. Transition zone prostate cancer: logistic regression and machine learning models, shapes and texture features are highly accurate for diagnostics. j Magneulison Imaging. 2019; 50:940–50.
Google Scholar
Varghese B, Chen F, Hwang D, Palmer SL, De Castro Abreu Al, Ukimura O, et al. Objective risk stratification of prostate cancer using machine learning and radiation applied to multiparametric magnetic resonance imaging. SciRep. 2019; 9:1570.
Google Scholar
Xu M, Fang M, Zou J, Yang S, Yu D, Zhong L, and others use signatures from the two parametric MRI radiation station to distinguish benign and malignant prostate lesions. Eur J Radio. 2019; 114:38–44.
Google Scholar
Min X, Li M, Dong D, Feng Z, Zhang P, Ke Z, and others Multiparametric MRI-based radiation signatures to distinguish clinically significant and insignificant prostate cancer: a cross-validation of machine learning methods. Eur J Radio. 2019; 115:16–21.
Google Scholar
Machine learning classifiers such as Antonelli M, Johnston EW, Dikaios N, Cheung KK, Sidhu HS, and Appayya MB can predict Gleason Pattern 4 prostate cancer with greater accuracy than experienced radiologists. Eur Radio. 2019; 29:4754–64.
Google Scholar
Bleker J, Kwee TC, Dierckx Rajo, de Jong IJ, Huisman H, Yakar D. Multi-trajectory measurements and automatic fixed volume of interest-based radiomics signatures for clinically important peripheral zone prostate cancer. Eur Radio. 2020; 30:1313–24.
Google Scholar
Gong L, Xu M, Fang M, Zou J, Yang S, Yu X, and others Noninvasive prediction of high-grade prostate cancer via biparametric MRI radiation. j Magneulison Imaging. 2020; 52:1102–9.
Google Scholar
Mehralivand S, Harmon SA, Shih JH, Smith CP, Lay N, Argun B, et al. Multicenter multi-leader evaluation of an artificial intelligence-based attentional mapping system for the detection of prostate cancer using multiparametric MRI. Ajr am J Roentgenol. 2020; 215:903–12.
Google Scholar
He D, Wang X, Fu C, Wei X, Bao J, Ji X, and others MRI-based radioactive model models to assess prostate cancer, ac extracutaneous elongation, and positive surgical margins. Cancer imaging. 2021; 21:46.
Google Scholar
Bertelli E, Mercatli L, Marzi C, Pachetti E, Baccini M, Barucci A, et al. Machine and deep learning prediction of prostate cancer aggression using multiparametric MRI. Front Oncol. 2022; 11:802964.
Google Scholar
Interactive and explainable deep learning models such as Hamm CA, BaumgärtnerGL, Biessmann F, Beetz NL, Hartenstein A, and Savic LJ inform prostate cancer diagnosis by MRI. Radiology. 2023; 307: E222276.
Google Scholar
Wang Z, Lu P, Liu S, Fu C, Ye Y, Yu C, et al. Comparison of the effects of rectal sensitivity artifacts in prostatic magnetic resonance imaging on subjective assessment and deep learning: a two-center retrospective study. BMC Med Imaging. 2025; 25:61.
Google Scholar
Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ and more Prostate Imaging Reports and Data System Version 2.1: 2019 Prostate Imaging Reports and Data System Version 2 Update. 2019; 76:340–51.
Google Scholar
Palumbo P, Manetta R, Izzo A, Bruno F, Arrigoni F, De Filippo M, and other diparametric (BP) and multiparametric (MP) magnetic resonance imaging (MRI) approaches to prostate cancer diseases: a narrative review of the current discussion of dynamic contrast enhancement. Adenosurgery. 2020; 9:2235–47.
Google Scholar
Schoots IG, Haider MA, Punwani S, Padhani AR. MRI in screening for prostate cancer: reviews and recommendations from the AJR special series on screening. Ajr am J Roentgenol. 2025; https://doi.org/10.2214/ajr.24.32588.
Bleker J, Yakar D, Van Noort B, Rouw D, De Jong IJ, Dierckx Rajo, and others Single-center, multicenter, two-sided measurement MRI radiation approach for clinically important peripheral zone prostate cancer. Insight Imaging. 2021; 12:150.
Google Scholar
Hiremath A, Shiradkar R, Fu P, Mahran A, Rastinehad AR, Tewari A, et al. Integrated nomograms combining clinical variables for the identification of clinically important prostate cancer in deep learning, prostate imaging reporting and data systems (PI-RADS) scoring, and bifacial accumulation MRI: a retrospective multicenter study. Lancet Digit Health. 2021; 3: E445 – E454.
Fully automatic deep learning in prostatic magnetic resonance imaging in Netzer N, WeißerC, Schelb P, Wang X, Qin X, GörtzM, and others: the effects of cohort size and heterogeneity. Invest in radio. 2021; 56:799–808.
Saha A, Hosseinzadeh M, Huisman H. Detection of end-to-end prostate cancer in BPMRI via 3D CNNS: Effects of attentional mechanisms, clinical a priori, and isolated false-positive reductions. Med Image Anal. 2021; 73:102155.
Google Scholar
DerezińskiP, Klupczynska A, Sawicki W, PałkaJA, Kokot ZJ. Serum and urinary amino acid profiles searching for biomarkers of prostate cancer: a pilot study. Int J Med Sci. 2017; 14:1–12.
Google Scholar
